Investors
8 investorsAll
Early stage
Mid stage
Late stage
Early stage· 2
Manuel Jaffrin
Tech Entrepreneur & Startup Investor. GetApp Co-founder (acquired by Gartner NYSE:IT), CSO@Nuclia (acquired by Progress Software)
early stage
17 investments
Dec 2021
Geoffrey B.
起死回生 — Entrepreneur | 2 exits | Scaling 2 companies in consumer health & tech
early stage
2 investments
Apr 2020
Mid stage· 5
Myriam Rouverand
VC Investor @Breega
Board Observer
mid stage
Jan 2024
Erwan Bernard
Entrepreneur & Investor | Building Builders Republic | Venture Partner @50 Partners
Board Member
mid stage
8 investments
Oct 2023
Thomas Fuster
PE Investor
tfuster@newalpha.net
Board Member
mid stage
6 investments
Sep 2023
Thomas Rival
Venture Capital Partner @ Evolem
Board Member
mid stage
70 investments
Sep 2022
Ulysse Laroche
GTM @ Nebius | VC & Startup Partnerships Lead, France & South Europe | Angel investor
mid stage
34 investments
Sep 2022
Investor geography2 countries
Investor activity2020–2025 · investors recorded per year
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Obat?
Obat has 8 investors on record on gritt.io, including 2 early-stage backers, 5 mid-stage and 1 late-stage investors.
When did Obat last raise funding?
The most recent investment in Obat recorded on gritt.io was in April 2025.
When was Obat founded?
Obat was founded in 2019.
What industry is Obat in?
Obat operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Obat based?
Obat is headquartered in Nantes, France.